FBInvestor
Stocks / Pharming Group NV
Institutional Ownership

Pharming Group NV

CUSIP 71716E105SPON ADSPHARQ1 2026

13D / 13G Filings
4
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
6.5%
Max % of class reported
Institutional Holders
11
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

4 filings · latest Apr 7, 2025

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Apr 7, 2025Morgan Stanley13G/A1.2%8.47MSEC
2Nov 14, 2024Rtw Investments, LP13G/ASEC
3Nov 8, 2024Morgan Stanley13G6.5%44.16MSEC
4Feb 14, 2024Rtw Investments, LP13G5.8%38.50MSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →